Cargando...
Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic model
Clinical benefit has been demonstrated in patients with head and neck tumours receiving an anti-epidermal growth factor receptor (EGFR) agent in combination with radiotherapy (RT). Recent preclinical and clinical studies suggest beneficial effects from combining anti-angiogenic drugs with RT. To inv...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2453013/ https://ncbi.nlm.nih.gov/pubmed/18577994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604429 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|